Streetbeat News

Earnings

MCD

McDonald's Corporation (NYSE:MCD) is experiencing a bearish trend, with key resistance levels forming due to buyer's remorse. The stock's ability to break through these resistance levels could signal a new uptrend, but failure to do so may result in continued downward movement.

Portfolio Pulse from Mark Putrino

July 29, 2024 | 7:21 pm

AAL

DAL

LUV

Delta Air Lines (DAL) shares are down 1.9% to $43.26, marking a 7.6% decrease for July. The stock was volatile last week, influenced by financial reports from American Airlines (AAL) and Southwest Airlines (LUV). Delta faces financial difficulties due to a system failure causing flight cancellations and a federal investigation. Citigroup cut Delta’s Q3 earnings estimate by 60 cents per share to $1.37, predicting a $350 million hit to operating profit and potential fines. Industry-wide issues like rising operating costs and capacity management challenges are also affecting Delta.

Portfolio Pulse from Henry Khederian

July 29, 2024 | 7:04 pm

AAPL

AMZN

GOOG

GOOGL

META

MSFT

TSLA

Big Tech stocks are expected to rebound this week as major companies like Microsoft, Amazon, Meta, and Apple report their earnings. Analysts believe that investments in AI will drive significant growth in the sector, despite last week's sell-off triggered by Alphabet and Tesla's earnings. The AI revolution is anticipated to fuel a multiyear bull run in tech stocks.

Portfolio Pulse from Michael Juliano

July 29, 2024 | 7:03 pm

XOM

Recent options trading trends for Exxon Mobil (NYSE:XOM) show a bearish stance among large investors, with 55% of trades being bearish. The trades indicate a targeted price range of $95.0 to $130.0. The stock is currently trading at $116.19, down by 0.97%, with an upcoming earnings report in 4 days.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 7:01 pm

BPMC

15 analysts have provided mixed ratings for Blueprint Medicines (NASDAQ:BPMC) in the latest quarter. The average 12-month price target has increased to $116.47, reflecting an 18.93% rise from the previous target. Analysts have raised their price targets, with the highest being $168.00 and the lowest $75.00. Blueprint Medicines has shown strong financial performance with significant revenue growth, high net margin, and effective debt management.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 7:01 pm

DECK

Deckers Outdoor shares are trading higher after multiple analysts raised their price targets on the stock following last week's earnings report.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 6:59 pm

CGTX

LIPO

NLSP

VERO

VTVT

VTYX

U.S. stocks were mostly higher towards the end of trading on Monday, with the Dow Jones slightly down by 0.04%. Notable stock movements included Lipella Pharmaceuticals, NLS Pharmaceutics, and Venus Concept, which saw significant gains, while vTv Therapeutics, Cognition Therapeutics, and Ventyx Biosciences experienced substantial declines.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 6:31 pm

ABEV

BUD

TAP

Beer shares, including Anheuser-Busch Inbev (NYSE:BUD), Ambev S.A. (NYSE:ABEV), and Molson Coors Beverage Company (NYSE:TAP), are trading lower following a weak earnings report from Heineken Holding N.V. (OTC:HKHHF). Heineken reported a net loss due to non-cash impairments, despite organic growth in beer volume. Upcoming earnings reports from these companies are causing market caution.

Portfolio Pulse from Vaishali Prayag

July 29, 2024 | 6:24 pm

DKNG

Recent options trading activity for DraftKings (NASDAQ:DKNG) shows a mixed sentiment among big-money investors, with a slight bearish tilt. Benzinga's options scanner detected 8 significant trades, with 3 puts and 5 calls, indicating a price window of $25.0 to $38.0. The stock is currently trading at $35.9, down by 1.1%, with an upcoming earnings report in 3 days. Analysts have mixed ratings, with an average target price of $54.6.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 6:16 pm

GS

Whales are showing a bullish stance on Goldman Sachs Gr (NYSE:GS) with 68% of recent options trades being bullish. Significant trades include calls with a total amount of $3.28M and puts with $459.78K. Analysts have mixed ratings with target prices ranging from $373 to $565.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 6:16 pm